Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Miravitlles

Showing results (61-70 of 564) with videos related to

Pageof 57
Sort By:
Respiratory Research|July 31, 2020
Tiotropium in chronic obstructive pulmonary disease - a review of clinical developmentAntonio Anzueto, Marc Miravitlles
COPD|February 6, 2015
Alpha1-antitrypsin deficiency: the contribution of national registries to the understanding of the disorder. A journal Supplement in memory of Professor Maurizio LuisettiMarc Miravitlles, Vito Brusasco
Current Opinion in Pulmonary Medicine|February 27, 2015
Role of infection in exacerbations of chronic obstructive pulmonary diseaseMarc Miravitlles, Antonio Anzueto
Archivos De Bronconeumologia|September 11, 2024
Etiotypes in COPD: a pro/con debateAlvar Agusti, Marc Miravitlles
Postgraduate Medicine|March 10, 2017
Pathophysiology of dyspnea in COPDAntonio Anzueto, Marc Miravitlles
Respiratory Research|April 23, 2017
Understanding the impact of symptoms on the burden of COPDMarc Miravitlles, Anna Ribera
Medicina Clinica|May 27, 2008
[Chronic obstructive pulmonary disease: disease or Zugzwang's syndrome?]Josep Morera, Marc Miravitlles
The European Respiratory Journal|December 18, 2025
Alvelestat for alpha-1 antitrypsin deficiency-associated emphysema: the hope for an oral treatmentDave Singh, Marc Miravitlles
Archivos De Bronconeumologia|April 8, 2018
Are There Differences Between the Available Treatments for Emphysema Associated with Alpha-1 Antitrypsin Deficiency?Cristina Esquinas, Marc Miravitlles
Clinical Drug Investigation|January 16, 2007
Determining factors in the prescription of moxifloxacin in exacerbations of chronic bronchitis in the primary-care settingMarc Miravitlles, Carles Llor
Pageof 57

Showing results (61-70 of 564) with videos related to

Sort By:
Pageof 57
Respiratory Research|July 31, 2020
Tiotropium in chronic obstructive pulmonary disease - a review of clinical developmentAntonio Anzueto, Marc Miravitlles
COPD|February 6, 2015
Alpha1-antitrypsin deficiency: the contribution of national registries to the understanding of the disorder. A journal Supplement in memory of Professor Maurizio LuisettiMarc Miravitlles, Vito Brusasco
Current Opinion in Pulmonary Medicine|February 27, 2015
Role of infection in exacerbations of chronic obstructive pulmonary diseaseMarc Miravitlles, Antonio Anzueto
Archivos De Bronconeumologia|September 11, 2024
Etiotypes in COPD: a pro/con debateAlvar Agusti, Marc Miravitlles
Postgraduate Medicine|March 10, 2017
Pathophysiology of dyspnea in COPDAntonio Anzueto, Marc Miravitlles
Respiratory Research|April 23, 2017
Understanding the impact of symptoms on the burden of COPDMarc Miravitlles, Anna Ribera
Medicina Clinica|May 27, 2008
[Chronic obstructive pulmonary disease: disease or Zugzwang's syndrome?]Josep Morera, Marc Miravitlles
The European Respiratory Journal|December 18, 2025
Alvelestat for alpha-1 antitrypsin deficiency-associated emphysema: the hope for an oral treatmentDave Singh, Marc Miravitlles
Archivos De Bronconeumologia|April 8, 2018
Are There Differences Between the Available Treatments for Emphysema Associated with Alpha-1 Antitrypsin Deficiency?Cristina Esquinas, Marc Miravitlles
Clinical Drug Investigation|January 16, 2007
Determining factors in the prescription of moxifloxacin in exacerbations of chronic bronchitis in the primary-care settingMarc Miravitlles, Carles Llor
Pageof 57